Skip to main content

Animations

MJFF Publications

2601 - 2610 of 9148 Results
Title
Year
  • Year
  • 2014
  • 2020
  • 2016
  • 2016
  • 2014
  • 2021
  • 2024
  • 2021
  • 2023
  • 2019
  • Summary Details
    OPEN
    Title: Cerebrospinal Fluid α-Synuclein Predicts Cognitive Decline in Parkinson Disease Progression in the DATATOP Cohort
    Journal Name: The American Journal of Pathology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.ajpath.2013.12.007
    Citation Count: 142
  • Summary Details
    OPEN
    Title: Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-020-02181-3
    Citation Count: 119
  • Summary Details
    OPEN
    Title: Overlap between Parkinson disease and Alzheimer disease in ABCA7 functional variants
    Journal Name: Neurology Genetics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/nxg.0000000000000044
    Citation Count: 40
  • Summary Details
    OPEN
    Title: Converging mediators from immune and trophic pathways to identify Parkinson disease dementia
    Journal Name: Neurology Neuroimmunology & Neuroinflammation
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/nxi.0000000000000193
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Course of psychiatric symptoms and global cognition in early Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000000801
    Citation Count: 121
  • Summary Details
    OPEN
    Title: Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000012868
    Citation Count: 189
  • Summary Details
    OPEN
    Title: Data‐driven disease progression model of Parkinson's disease and effect of sex and genetic variants
    Journal Name: CPT: Pharmacometrics & Systems Pharmacology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/psp4.13112
    Citation Count: 11
  • Summary Details
    OPEN
    Title: The 3-Item “Apathy” Subscale Within the GDS-15 Is Not Supported in De Novo Parkinson’s Disease Patients: Analysis of the PPMI Cohort
    Journal Name: Journal of Geriatric Psychiatry and Neurology
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1177/0891988720988908
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Longitudinal dysregulation of long non-coding RNAs in Parkinson’s disease
    Journal Name: Experimental Biology and Medicine
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1177/15353702231198078
    Citation Count: 3
  • Summary Details
    RESTRICTED
    Title: Abstract
    Journal Name: Brain and Neuroscience Advances
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/2398212819855490
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.